BETA ADRENERGIC BLOCKERS

• ALL BETA ADRENERGIC BLOCKERS ARE EQUALLY EFFECTIVE IN THE TREATMENT OF HYPERTENSION.



• CARDIOSELECTIVE BETA BLOCKERS BECOME LESS SELECTIVE AS THE DOSE INCREASED.



• ADVANTAGES IN PATIENT WITH DIABETES OR CHRONIC LUNG DISEASE.



• AFRICAN ARE MORE RESPONSIVE TO DIURETICS AND CALCIUM ENTRY BLOCKERS THAN BETA BLOCKERS AND ACE INHIBITORS.



• BETA BLOCKERS ARE MORE EFFECTIVE IN WHITE THAN BLACKS.



• CARDIOPROTECTIVE EFFECT



• REDUCE MORTALITY WITH CORONARY HEART DISEASE.



• DECREASED HDL CHOLESTEROL, INCREASED LDL CHOLESTEROL. [AVOIDED IN PATIENT WITH ELEVATED LDL CHOLESTEROL LEVEL].



• BETA BLOCKERS SHOULD BE AVOIDED IN DIABETES [MASL HYPOGLYCEMIA SYMPTOMS]



• LIPOPHILIC BETA BLOCKERS: PROPANOLOL

ACEBUTOLOL

TIMOLOL

METOPROLOL

PINDOLOL

CARDIOSELECTIVE BETA BLOCKERS	NON CARDIOSELECTIVE BETA BLOCKERS
METOPROLOL = LOPRESSOR	PROPANOLOL LA =INDERAL LA
ATENOLOL = TENORMIN	TIMOLOL=BLOCADREN
	NADOLOL=CORGARD
	PINDOLOL=VISKEN
	CARTEOLOL=CARTROL